Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.
Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.
Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder
The centre’s cofounders include UC Berkeley neuroscientist David Presti, psychologist Dacher Keltner, and journalism professor Michael Pollan
Health Minister Patty Hajdu has given its wholly owned subsidiary the green light to possess pure psilocybin for research purposes.
For the past decade, executive director Mark Haden has been educating physicians on how these molecules could help patients with posttraumatic stress disorder, treatment-resistant depression, and other conditions
Health Canada allows certain companies to conduct research on drugs
Four patients battling cancer seek psilocybin-assisted psychotherapy
West Vancouver counsellor says psychedelics need to be handled by trained and experienced professionals